165 related articles for article (PubMed ID: 37845573)
1. Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Tanday N; Tarasov AI; Moffett RC; Flatt PR; Irwin N
Diabetes Obes Metab; 2024 Jan; 26(1):16-31. PubMed ID: 37845573
[TBL] [Abstract][Full Text] [Related]
2. Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas.
Tritschler S; Theis FJ; Lickert H; Böttcher A
Mol Metab; 2017 Sep; 6(9):974-990. PubMed ID: 28951822
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced adaptive islet cell identity changes.
Cigliola V; Thorel F; Chera S; Herrera PL
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):87-96. PubMed ID: 27615136
[TBL] [Abstract][Full Text] [Related]
4. β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
Mezza T; Cinti F; Cefalo CMA; Pontecorvi A; Kulkarni RN; Giaccari A
Diabetes; 2019 Jun; 68(6):1121-1129. PubMed ID: 31109941
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the Endogenous Plasticity of Pancreatic Islets: A Feasible Regenerative Medicine Therapy for Diabetes?
Lorenzo PI; Cobo-Vuilleumier N; Martín-Vázquez E; López-Noriega L; Gauthier BR
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921851
[TBL] [Abstract][Full Text] [Related]
6. The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity.
Ilegems E; Berggren PO
Front Endocrinol (Lausanne); 2021; 12():652853. PubMed ID: 33967961
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
Tanday N; Flatt PR; Irwin N; Moffett RC
J Endocrinol; 2020 Apr; 245(1):53-64. PubMed ID: 31977315
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Tanday N; Irwin N; Flatt PR; Moffett RC
Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic β-cell identity in diabetes.
Remedi MS; Emfinger C
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):110-6. PubMed ID: 27615139
[TBL] [Abstract][Full Text] [Related]
11. Role of islet peptides in beta cell regulation and type 2 diabetes therapy.
Khan D; Moffet CR; Flatt PR; Kelly C
Peptides; 2018 Feb; 100():212-218. PubMed ID: 29412821
[TBL] [Abstract][Full Text] [Related]
12. Update on the transdifferentiation of pancreatic cells into functional beta cells for treating diabetes.
Spezani R; Reis-Barbosa PH; Mandarim-de-Lacerda CA
Life Sci; 2024 Jun; 346():122645. PubMed ID: 38614297
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model.
Villaça CBP; de Paula CC; de Oliveira CC; Vilas-Boas EA; Dos Santos-Silva JC; de Oliveira SF; Abdulkader F; Ferreira SM; Ortis F
Exp Physiol; 2021 Jul; 106(7):1482-1497. PubMed ID: 33913203
[TBL] [Abstract][Full Text] [Related]
14. XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice.
Lee K; Chan JY; Liang C; Ip CK; Shi YC; Herzog H; Hughes WE; Bensellam M; Delghingaro-Augusto V; Koina ME; Nolan CJ; Laybutt DR
Diabetologia; 2022 Jun; 65(6):984-996. PubMed ID: 35316840
[TBL] [Abstract][Full Text] [Related]
15. Islet Neogenesis Associated Protein (INGAP) induces the differentiation of an adult human pancreatic ductal cell line into insulin-expressing cells through stepwise activation of key transcription factors for embryonic beta cell development.
Assouline-Thomas B; Ellis D; Petropavlovskaia M; Makhlin J; Ding J; Rosenberg L
Differentiation; 2015; 90(4-5):77-90. PubMed ID: 26558987
[TBL] [Abstract][Full Text] [Related]
16. Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice.
Sarnobat D; Lafferty RA; Charlotte Moffett R; Tarasov AI; Flatt PR; Irwin N
J Pharm Pharmacol; 2022 Nov; 74(12):1758-1764. PubMed ID: 36206181
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional control of pancreatic β-cell identity and plasticity during the pathogenesis of type 2 diabetes.
Zhang Z; Gao Y; Meng ZX
J Genet Genomics; 2022 Apr; 49(4):316-328. PubMed ID: 35292418
[TBL] [Abstract][Full Text] [Related]
18. Role of transcription factors in the transdifferentiation of pancreatic islet cells.
van der Meulen T; Huising MO
J Mol Endocrinol; 2015 Apr; 54(2):R103-17. PubMed ID: 25791577
[TBL] [Abstract][Full Text] [Related]
19. GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic mice.
Sarnobat D; Charlotte Moffett R; Flatt PR; Irwin N; Tarasov AI
Biochem Pharmacol; 2022 May; 199():115019. PubMed ID: 35358478
[TBL] [Abstract][Full Text] [Related]
20. Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1
Tanday N; Moffett RC; Gault VA; Flatt PR; Irwin N
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3384. PubMed ID: 32662136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
